Leadart Biotechnologies
- Biotech or pharma, therapeutic R&D
LeadArt Biotechnologies provides a powerful platform for pharma and biotech partners to accelerate target mapping and ligand screening through live-cell chemoproteomics, automation, and AI.
- Our automated Target Space Station™ enables high-throughput chemoproteomics sample preparation (>20,000 samples/year/unit), reducing time and cost while generating high-quality, proteome-wide target engagement data across diverse compound libraries and live cell types.
- Our patented INTRAP™ technology enables selective, in-cell ligand screening against even challenging targets—without the need for protein purification—preserving native structure and biological context.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}